EARLY RESULTS OF REDUCED-DOSE RADIOTHERAPY PLUS CHEMOTHERAPY FOR CHILDREN WITH NONDISSEMINATED MEDULLOBLASTOMA - A CHILDRENS CANCER GROUP-STUDY

被引:0
|
作者
PACKER, RJ
GOLDWEIN, JW
BOYETT, J
NICHOLSON, HS
COHEN, BH
RIS, MD
WARA, W
ALLEN, J
RORKE, L
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:518 / 518
页数:1
相关论文
共 50 条
  • [21] Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology study
    Oyharcabal-Bourden, V
    Kalifa, C
    Gentet, JC
    Frappaz, D
    Edan, C
    Chastagner, P
    Sariban, E
    Pagnier, A
    Babin, A
    Pichon, F
    Neuenschwander, S
    Vinchon, M
    Bours, D
    Mosseri, V
    Le Gales, C
    Ruchoux, M
    Carrie, C
    Doz, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4726 - 4734
  • [22] HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) WITH CHEMOTHERAPY FOR METASTATIC MEDULLOBLASTOMA (MB): PRELIMINARY REPORT OF THE CHILDREN'S CANCER AND LEUKAEMIA GROUP (CCLG) STUDY
    Taylor, R. E.
    Boota, N.
    Bujkiewicz, S.
    Lucas, J.
    Robinson, K. J.
    Robson, K.
    Saran, F.
    Michalski, A.
    Pizer, B.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1082 - 1083
  • [23] Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma)
    Goldwein, JW
    Radcliffe, J
    Johnson, J
    Moshang, T
    Packer, RJ
    Sutton, LN
    Rorke, LB
    DAngio, GJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (04): : 899 - 904
  • [24] cGy of craniospinal radiotherapy (CSRT) plus chemotherapy for children with "average-risk" medulloblastoma (MB): A prospective randomized children's oncology group study (A9961)
    Packer, RJ
    Gajjar, A
    Vezina, G
    Langston, J
    Rorke, L
    Burger, P
    Robertson, P
    Murasko, K
    Armstrong, D
    Ris, D
    LaFond, D
    Boyer, L
    Sposto, R
    NEURO-ONCOLOGY, 2004, 6 (04) : 387 - 387
  • [25] Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961
    Packer, Roger J.
    Zhou, Tianni
    Holmes, Emi
    Vezina, Gilbert
    Gajjar, Amar
    NEURO-ONCOLOGY, 2013, 15 (01) : 97 - 103
  • [27] RESULTS OF RANDOMIZED CHEMOTHERAPY TRIALS FOR NEWLY DIAGNOSED MEDULLOBLASTOMA, MALIGNANT ASTROCYTOMA, AND BRAIN-STEM GLIOMA FROM THE CHILDRENS CANCER STUDY-GROUP
    ALLEN, J
    ERTEL, I
    EVANS, A
    JENKIN, D
    SPOSTO, R
    HAMMOND, D
    ANNALS OF NEUROLOGY, 1984, 16 (03) : 403 - 403
  • [28] Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma
    Lee, Ji Won
    Lim, Do Hoon
    Sung, Ki Woong
    Cho, Hee Won
    Ju, Hee Young
    Hyun, Ju Kyung
    Yoo, Keon Hee
    Koo, Hong Hoe
    Suh, Yeon-Lim
    Joung, Yoo-Sook
    Shin, Hyung Jin
    CANCER MEDICINE, 2020, 9 (16): : 5807 - 5818
  • [29] Efficacy and safety of reduced-dose chemotherapy plus immunotherapy in patients with lung squamous cell carcinoma: A real-world observational study
    Ouyang, Ganlu
    Liu, Yanyang
    Liu, Jiewei
    Huang, Lin
    Luo, Feng
    Li, Lu
    CANCER MEDICINE, 2023, 12 (18): : 18679 - 18690
  • [30] Children's Cancer and Leukemia Group (CCLG) Study of Hyperfractionated Accelerated Radiotherapy (HART) with Chemotherapy for M1-3 Medulloblastoma (MB)
    Taylor, R. E.
    Boota, N.
    Bujkiewicz, S.
    Lucas, J.
    Robinson, K.
    Saran, F.
    Michalski, A.
    Pizer, B. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S38 - S38